HLA-E and cancer: The expression of HLA-E, along with the increased levels of CD94/NKG2A observed in tumor-infiltrating lymphocytes (TILs), has been associated with tumor progression, metastasis, and decreased patient survival rates in certain cancers [20,21,22].